Scagnetto A - Search Results

1

Effectiveness of PCSK9 inhibitors: A Target Trial Emulation framework based on Real-World Electronic Health Records.

Barbati G, Gregorio C, Scagnetto A, Indennidate C, Cappelletto C, Di Lenarda A. Barbati G, et al. Among authors: scagnetto a. PLoS One. 2024 Aug 22;19(8):e0309470. doi: 10.1371/journal.pone.0309470. eCollection 2024. PLoS One. 2024. PMID: 39173034 Free PMC article.

2

[Focus on heart failure with preserved ejection fraction: from trials to the real world of the Friuli-Venezia Giulia Cardiovascular Observatory].

Di Lenarda A, Cittar M, Cappelletto C, Mattei L, Cherubini A, Radini D, Scagnetto A, Iorio A, Barbati G, Faganello G, Russo G. Di Lenarda A, et al. Among authors: scagnetto a. G Ital Cardiol (Rome). 2024 Aug;25(8):557-566. doi: 10.1714/4309.42925. G Ital Cardiol (Rome). 2024. PMID: 39072594 Review. Italian.

3

Flexible Approaches Based on Multistate Models and Microsimulation to Perform Real-World Cost-Effectiveness Analyses: An Application to Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors.

Gregorio C, Rea F, Ieva F, Scagnetto A, Indennidate C, Cappelletto C, Di Lenarda A, Barbati G. Gregorio C, et al. Among authors: scagnetto a. Value Health. 2024 Jul;27(7):897-906. doi: 10.1016/j.jval.2024.03.008. Epub 2024 Mar 26. Value Health. 2024. PMID: 38548178 Free article.

4

Comparison of discrimination and calibration performance of ECG-based machine learning models for prediction of new-onset atrial fibrillation.

Baj G, Gandin I, Scagnetto A, Bortolussi L, Cappelletto C, Di Lenarda A, Barbati G. Baj G, et al. Among authors: scagnetto a. BMC Med Res Methodol. 2023 Jul 22;23(1):169. doi: 10.1186/s12874-023-01989-3. BMC Med Res Methodol. 2023. PMID: 37481514 Free PMC article.

5

Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: A retrospective cohort study.

Gandin I, Saccani S, Coser A, Scagnetto A, Cappelletto C, Candido R, Barbati G, Di Lenarda A. Gandin I, et al. Among authors: scagnetto a. PLoS One. 2023 Feb 21;18(2):e0281878. doi: 10.1371/journal.pone.0281878. eCollection 2023. PLoS One. 2023. PMID: 36809251 Free PMC article.

6

Patient adherence to drug treatment in a community based-sample of patients with chronic heart failure.

Rea F, Iorio A, Barbati G, Bessi R, Castrichini M, Nuzzi V, Scagnetto A, Senni M, Corrao G, Sinagra G, Di Lenarda A. Rea F, et al. Among authors: scagnetto a. Int J Cardiol. 2022 Feb 15;349:144-149. doi: 10.1016/j.ijcard.2021.11.018. Epub 2021 Nov 18. Int J Cardiol. 2022. PMID: 34801616 Free article. No abstract available.

7

Interpretability of time-series deep learning models: A study in cardiovascular patients admitted to Intensive care unit.

Gandin I, Scagnetto A, Romani S, Barbati G. Gandin I, et al. Among authors: scagnetto a. J Biomed Inform. 2021 Sep;121:103876. doi: 10.1016/j.jbi.2021.103876. Epub 2021 Jul 27. J Biomed Inform. 2021. PMID: 34325021 Free article.

8

Sex-related differences in chronic heart failure: a community-based study.

Russo G, Rea F, Barbati G, Cherubini A, Stellato K, Scagnetto A, Iorio A, Corrao G, Di Lenarda A. Russo G, et al. Among authors: scagnetto a. J Cardiovasc Med (Hagerstown). 2021 Jan;22(1):36-44. doi: 10.2459/JCM.0000000000001049. J Cardiovasc Med (Hagerstown). 2021. PMID: 32740424

9

CHA₂DS₂-VASc Score Predicts Adverse Outcome in Patients with Simple Congenital Heart Disease Regardless of Cardiac Rhythm.

Faganello G, Barbati G, Russo G, Scagnetto A, Mazzone C, Mottolese BD', Zaccari M, Sinagra G, Lenarda AD, Cioffi G. Faganello G, et al. Among authors: scagnetto a. Pediatr Cardiol. 2020 Jun;41(5):1051-1057. doi: 10.1007/s00246-020-02356-5. Epub 2020 May 5. Pediatr Cardiol. 2020. PMID: 32372107 Free article.

10

Adherence to Disease-Modifying Therapy in Patients Hospitalized for HF: Findings from a Community-Based Study.

Spreafico M, Gasperoni F, Barbati G, Ieva F, Scagnetto A, Zanier L, Iorio A, Sinagra G, Di Lenarda A. Spreafico M, et al. Among authors: scagnetto a. Am J Cardiovasc Drugs. 2020 Apr;20(2):179-190. doi: 10.1007/s40256-019-00367-z. Am J Cardiovasc Drugs. 2020. PMID: 31444666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters